{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:17:02Z","timestamp":1781777822005,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"DOI":"10.7759\/cureus.47698","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T07:47:14Z","timestamp":1698306434000},"source":"Crossref","is-referenced-by-count":2,"title":["Rasmussen\u2019s Encephalitis: A Literary Review"],"prefix":"10.7759","author":[{"given":"Abhishek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshil","family":"Krishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arundhati","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.8.6.435","article-title":"Focal seizures due to chronic localized encephalitis","volume":"8","author":"Rasmussen T","year":"1958","unstructured":"Rasmussen T, Olszewski J, Lloyd\u2010Smith D. Focal seizures due to chronic localized encephalitis. Neurology. 1958, 8:435-45. 10.1212\/wnl.8.6.435","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10100","article-title":"Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis","volume":"51","author":"Bien CG","year":"2002","unstructured":"Bien CG, Bauer J, Deckwerth TL, et al.. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol. 2002, 51:311-18. 10.1002\/ana.10100","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530330016002","article-title":"Chronic encephalitis and epilepsy","volume":"49","author":"Dreifuss FE","year":"1992","unstructured":"Dreifuss FE. Chronic encephalitis and epilepsy. Arch Neurol. 1992, 49:898. 10.1001\/archneur.1992.00530330016002","journal-title":"Arch Neurol"},{"key":"ref4","article-title":"The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases","volume":"57","author":"Oguni H","year":"1992","unstructured":"Oguni H, Andermann F, Rasmussen TB. The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv Neurol. 1992, 57:419-33.","journal-title":"Adv Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.4.738","article-title":"Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy","volume":"52","author":"Leach JP","year":"1999","unstructured":"Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology. 1999, 52:738-42. 10.1212\/wnl.52.4.738","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12042","article-title":"Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins","volume":"54","author":"Bien CG","year":"2013","unstructured":"Bien CG, Tiemeier H, Sassen R, et al.. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia. 2013, 54:543-50. 10.1111\/epi.12042","journal-title":"Epilepsia"},{"key":"ref7","article-title":"Prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom","volume":"55","author":"Lamb K","year":"2013","unstructured":"Lamb K, Scott WJ, Mensah A, et al.. Prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom. Dev Med Child Neurol. 2013, 55:14.","journal-title":"Dev Med Child Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03565.x","article-title":"Evolution of the EEG in children with Rasmussen's syndrome","volume":"53","author":"Longaretti F","year":"2012","unstructured":"Longaretti F, Dunkley C, Varadkar S, Vargha-Khadem F, Boyd SG, Cross JH. Evolution of the EEG in children with Rasmussen's syndrome. Epilepsia. 2012, 53:1539-45. 10.1111\/j.1528-1167.2012.03565.x","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000128044.94294.87","article-title":"An open study of tacrolimus therapy in Rasmussen encephalitis","volume":"62","author":"Bien CG","year":"2004","unstructured":"Bien CG, Gleissner U, Sassen R, Widman G, Urbach H, Elger CE. An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology. 2004, 62:2106-9. 10.1212\/01.wnl.0000128044.94294.87","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.2.418","article-title":"Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome?","volume":"48","author":"Hart YM","year":"1997","unstructured":"Hart YM, Andermann F, Fish DR, et al.. Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome?. Neurology. 1997, 48:418-24. 10.1212\/wnl.48.2.418","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000028709","article-title":"Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia","volume":"29","author":"Bhatjiwale MG","year":"1998","unstructured":"Bhatjiwale MG, Polkey C, Cox TC, Dean A, Deasy N. Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg. 1998, 29:142-8. 10.1159\/000028709","journal-title":"Pediatr Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01684.x Abstract","article-title":"Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures","volume":"14","author":"Bien CG","year":"2007","unstructured":"Bien CG, Elger CE, Leitner Y, et al.. Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures. Eur J Neurol. 2007, 14:387-90. 10.1111\/j.1468-1331.2007.01684.x Abstract","journal-title":"Eur J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000115393.67403.53","article-title":"Rasmussen encephalitis with active inflammation and delayed seizures onset","volume":"62","author":"Korn-Lubetzki I","year":"2004","unstructured":"Korn-Lubetzki I, Bien CG, Bauer J, et al.. Rasmussen encephalitis with active inflammation and delayed seizures onset. Neurology. 2004, 62:984-6. 10.1212\/01.wnl.0000115393.67403.53","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.2.250","article-title":"Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology","volume":"58","author":"Bien CG","year":"2002","unstructured":"Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, Elger CE. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology. 2002, 58:250-7. 10.1212\/wnl.58.2.250","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.33103.x","article-title":"The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies","volume":"45","author":"Pardo CA","year":"2004","unstructured":"Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia. 2004, 45:516-26. 10.1111\/j.0013-9580.2004.33103.x","journal-title":"Epilepsia"},{"key":"ref16","article-title":"Neuropathologic aspects of chronic encephalitis","author":"Robitaille Y","year":"1991","unstructured":"Robitaille Y. Neuropathologic aspects of chronic encephalitis. Chronic Encephalitis and Epilepsy: Rasmussen\u2019s Syndrome. Andermann F (ed): Butterworth-Heinemann, Boston; 1991. 110."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-010-0481-0","article-title":"Molecular and cellular mechanisms of excitotoxic neuronal death","volume":"15","author":"Wang Y","year":"2010","unstructured":"Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis. 2010, 15:1382-402. 10.1007\/s10495-010-0481-0","journal-title":"Apoptosis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent A","year":"2011","unstructured":"Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011, 10:759-72. 10.1016\/S1474-4422(11)70096-5","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers SW","year":"1994","unstructured":"Rogers SW, Andrews PI, Gahring LC, et al.. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science. 1994, 265:648-51. 10.1126\/science.8036512","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000099074.04539.e0","article-title":"Experience with immunomodulatory treatments in Rasmussen's encephalitis","volume":"61","author":"Granata T","year":"2003","unstructured":"Granata T, Fusco L, Gobbi G, et al.. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology. 2003, 61:1807-10. 10.1212\/01.wnl.0000099074.04539.e0","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90219-8","article-title":"Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site","volume":"14","author":"Twyman RE","year":"1995","unstructured":"Twyman RE, Gahring LC, Spiess J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron. 1995, 14:755-62. 10.1016\/0896-6273(95)90219-8","journal-title":"Neuron"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp003","article-title":"CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery","volume":"132","author":"Schwab N","year":"2009","unstructured":"Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, Wiendl H. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain. 2009, 132:1236-46. 10.1093\/brain\/awp003","journal-title":"Brain"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21148","article-title":"Astrocytes are a specific immunological target in Rasmussen's encephalitis","volume":"62","author":"Bauer J","year":"2007","unstructured":"Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol. 2007, 62:67-80. 10.1002\/ana.21148","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.1.108","article-title":"Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization","volume":"45","author":"Jay V","year":"1995","unstructured":"Jay V, Becker LE, Otsubo H, Cortez M, Hwang P, Hoffman HJ, Zielenska M. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology. 1995, 45:108-17. 10.1212\/wnl.45.1.108","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-56","article-title":"Differential expression of interferon-\u03b3 and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response","volume":"10","author":"Owens GC","year":"2013","unstructured":"Owens GC, Huynh MN, Chang JW, et al.. Differential expression of interferon-\u03b3 and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation. 2013, 10:56. 10.1186\/1742-2094-10-56","journal-title":"J Neuroinflammation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.02.015","article-title":"Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex","volume":"34","author":"Wirenfeldt M","year":"2009","unstructured":"Wirenfeldt M, Clare R, Tung S, Bottini A, Mathern GW, Vinters HV. Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex. Neurobiol Dis. 2009, 34:432-40. 10.1016\/j.nbd.2009.02.015","journal-title":"Neurobiol Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan AH","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012, 35:369-89. 10.1146\/annurev-neuro-061010-113810","journal-title":"Annu Rev Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22312","article-title":"Astrocyte immune responses in epilepsy","volume":"60","author":"Aronica E","year":"2012","unstructured":"Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia. 2012, 60:1258-68. 10.1002\/glia.22312","journal-title":"Glia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01977.x","article-title":"A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF","volume":"50","author":"Takahashi Y","year":"2009","unstructured":"Takahashi Y, Mine J, Kubota Y, Yamazaki E, Fujiwara T. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF. Epilepsia. 2009, 50:1419-31. 10.1111\/j.1528-1167.2008.01977.x","journal-title":"Epilepsia"},{"key":"ref30","article-title":"Pharmacologic principles in the management of chronic focal encephalitis","author":"Dubeau F","year":"1991","unstructured":"Dubeau F, Sherwin AL. Pharmacologic principles in the management of chronic focal encephalitis. Chronic Encephalitis and Epilepsy Rasmussen\u2019s Syndrome. Andermann F (ed): Butterworth-Heinemann, Boston; 1991. 179-92."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20991","article-title":"Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis","volume":"21","author":"Browner N","year":"2006","unstructured":"Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord. 2006, 21:1500-2. 10.1002\/mds.20991","journal-title":"Mov Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000118283.51400.7a","article-title":"Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome","volume":"62","author":"Lozsadi DA","year":"2004","unstructured":"Lozsadi DA, Hart IK, Moore AP. Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome. Neurology. 2004, 62:1233-4. 10.1212\/01.wnl.0000118283.51400.7a","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.136","article-title":"Case report: Rasmussen\u2019s encephalitis treated successfully with rituximab","volume":"5","author":"Lockman J","year":"2013","unstructured":"Lockman J, Le S, Fisher R S., et al.. Case report: Rasmussen\u2019s encephalitis treated successfully with rituximab. Cureus. 2013, 5:136. 10.7759\/cureus.136","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.06.001","article-title":"Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma","volume":"86","author":"Bien CG","year":"2009","unstructured":"Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res. 2009, 86:101-12. 10.1016\/j.eplepsyres.2009.06.001","journal-title":"Epilepsy Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01096.x","article-title":"Clinical and electroencephalographic correlates in Rasmussen's encephalitis","volume":"38","author":"Andrews PI","year":"1997","unstructured":"Andrews PI, McNamara JO, Lewis DV. Clinical and electroencephalographic correlates in Rasmussen's encephalitis. Epilepsia. 1997, 38:189-94. 10.1111\/j.1528-1157.1997.tb01096.x","journal-title":"Epilepsia"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.44.6.1030","article-title":"Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients","volume":"44","author":"Hart YM","year":"1994","unstructured":"Hart YM, Cortez M, Andermann F, et al.. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology. 1994, 44:1030-6. 10.1212\/wnl.44.6.1030","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of glucocorticoids","volume":"29","author":"Vandewalle J","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018, 29:42-54. 10.1016\/j.tem.2017.10.010","journal-title":"Trends Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020444","article-title":"Clinical use and molecular action of corticosteroids in the pediatric age","volume":"20","author":"Ferrara G","year":"2019","unstructured":"Ferrara G, Petrillo MG, Giani T, et al.. Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci. 2019, 20:444. 10.3390\/ijms20020444","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.10.033","article-title":"Autoimmune neurologic disorders","volume":"131","author":"Rubin DB","year":"2018","unstructured":"Rubin DB, Batra A, Vaitkevicius H, Vodopivec I. Autoimmune neurologic disorders. Am J Med. 2018, 131:226-36. 10.1016\/j.amjmed.2017.10.033","journal-title":"Am J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.07.023","article-title":"Rasmussen's encephalitis: from immune pathogenesis towards targeted-therapy","volume":"81","author":"Orsini A","year":"2020","unstructured":"Orsini A, Foiadelli T, Carli N, et al.. Rasmussen's encephalitis: from immune pathogenesis towards targeted-therapy. Seizure. 2020, 81:76-83. 10.1016\/j.seizure.2020.07.023","journal-title":"Seizure"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Nimmerjahn F","year":"2007","unstructured":"Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007, 204:11-15. 10.1084\/jem.20061788","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.2.248","article-title":"Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis","volume":"56","author":"Villani F","year":"2001","unstructured":"Villani F, Spreafico R, Farina L, Giovagnoli AR, Bernasconi P, Granata T, Avanzini G. Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology. 2001, 56:248-50. 10.1212\/wnl.56.2.248","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.46.1.242","article-title":"Plasmapheresis in Rasmussen's encephalitis","volume":"46","author":"Andrews PI","year":"1996","unstructured":"Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen's encephalitis. Neurology. 1996, 46:242-6. 10.1212\/wnl.46.1.242","journal-title":"Neurology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2022.01.007","article-title":"Medical treatment of Rasmussen\u2019s encephalitis: a systematic review","volume":"178","author":"Lagarde S","year":"2022","unstructured":"Lagarde S, Boucraut J, Bartolomei F. Medical treatment of Rasmussen\u2019s encephalitis: a systematic review. Rev Neurol (Paris). 2022, 178:675-91. 10.1016\/j.neurol.2022.01.007","journal-title":"Rev Neurol (Paris)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14020","article-title":"Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations","volume":"61","author":"Nosadini M","year":"2019","unstructured":"Nosadini M, Gadian J, Lim M, Sartori S, Thomas T, Dale RC. Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations. Dev Med Child Neurol. 2019, 61:458-68. 10.1111\/dmcn.14020","journal-title":"Dev Med Child Neurol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-8994(03)00216-9","article-title":"Rasmussen syndrome and long-term response to thalidomide","volume":"29","author":"Marjanovic BD","year":"2003","unstructured":"Marjanovic BD, Stojanov LM, Zdravkovic DS, Kravljanac RM, Djordjevic MS. Rasmussen syndrome and long-term response to thalidomide. Ped neurol. 2003, 29:151-6. 10.1016\/s0887-8994(03)00216-9","journal-title":"Ped neurol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.10.018","article-title":"Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy","volume":"108","author":"Bamias A","year":"2008","unstructured":"Bamias A, Koutsoukou V, Terpos E, et.al.. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy. Gynecol Oncol. 2008, 108:421-7. 10.1016\/j.ygyno.2007.10.018","journal-title":"Gynecol Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70260-6","article-title":"Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances","volume":"13","author":"Varadkar S","year":"2014","unstructured":"Varadkar S, Bien CG, Kruse CA, et al.. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014, 13:195-205. 10.1016\/S1474-4422(13)70260-6","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183977-rasmussens-encephalitis-a-literary-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:47Z","timestamp":1707509267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183977-rasmussens-encephalitis-a-literary-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.47698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}